KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Novavax (NVAX) over the last 13 years, with Q3 2025 value amounting to $658000.0.

  • Novavax's Exchange Rate Effect fell 8908.43% to $658000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 15284.54%. This contributed to the annual value of -$7.8 million for FY2024, which is 33838.63% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Exchange Rate Effect is $658000.0, which was down 8908.43% from $7.9 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Exchange Rate Effect registered a high of $9.3 million during Q3 2023, and its lowest value of -$10.7 million during Q4 2024.
  • Over the past 5 years, Novavax's median Exchange Rate Effect value was $658000.0 (recorded in 2025), while the average stood at $122842.1.
  • As far as peak fluctuations go, Novavax's Exchange Rate Effect tumbled by 231152.26% in 2021, and later soared by 516794.87% in 2025.
  • Quarter analysis of 5 years shows Novavax's Exchange Rate Effect stood at $916000.0 in 2021, then surged by 365.39% to $4.3 million in 2022, then plummeted by 31.57% to $2.9 million in 2023, then crashed by 467.4% to -$10.7 million in 2024, then soared by 106.14% to $658000.0 in 2025.
  • Its last three reported values are $658000.0 in Q3 2025, $7.9 million for Q2 2025, and -$930000.0 during Q1 2025.